Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

PeptiDream

Market Cap: JP¥217.1b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥24.5b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

CK Life Sciences Int'l. (Holdings)

Market Cap: HK$8.3b

An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.

Kangmei Pharmaceutical

Market Cap: CN¥27.3b

Produces and sells Chinese herbal medicines in China.

Sam Chun Dang Pharm

Market Cap: ₩3.3t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$8.3b

An investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.

Everest Medicines

Market Cap: HK$14.1b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Bio-Thera Solutions

Market Cap: CN¥9.9b

A biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally.

Samsung BiologicsLtd

Market Cap: ₩76.9t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Akeso

Market Cap: HK$77.2b

A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.

Lonza Group

Market Cap: CHF 39.6b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

BridgeBio Pharma

Market Cap: US$6.2b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Trulieve Cannabis

Market Cap: CA$14.8b

Operates as a cannabis retailer.

Rhythm Pharmaceuticals

Market Cap: US$4.0b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

BeiGene

Market Cap: US$25.6b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Novavax

Market Cap: US$1.2b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Krystal Biotech

Market Cap: US$3.7b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Janux Therapeutics

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Evotec

Market Cap: €1.2b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Teva Pharmaceutical Industries

Market Cap: US$19.0b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Bavarian Nordic

Market Cap: DKK 13.2b

Develops, manufactures, and supplies life-saving vaccines.

Bio-Rad Laboratories

Market Cap: US$6.3b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Vertex Pharmaceuticals

Market Cap: US$111.8b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Denali Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

Harmony Biosciences Holdings

Market Cap: US$2.0b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Revvity

Market Cap: US$10.6b

Provides health sciences solutions, technologies, and services worldwide.

IQVIA Holdings

Market Cap: US$23.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Cytokinetics

Market Cap: US$3.7b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Roivant Sciences

Market Cap: US$7.8b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Summit Therapeutics

Market Cap: US$18.9b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Dottikon ES Holding

Market Cap: CHF 2.9b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.

Viking Therapeutics

Market Cap: US$3.1b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Prestige Consumer Healthcare

Market Cap: US$4.2b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Repligen

Market Cap: US$6.8b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.